Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of British Columbia

$125,000.00

A Single Cell Isolating System for Genomics Applications, Phase 1 I2I

EF 2019-20

Résumé
The UBC Isolatrix printer will be a cost-effective solution to fill an unmet need for single-cell preparation for numerous use cases. Current methods for single-cell isolation include random encapsulation and micromanipulation. Random encapsulation following the Poisson distribution gives a low fill factor with a large number of empty wells or droplets, while current tools using micromanipulation can increase the fill factor but with high shear force on cells, or high processing time. Our system is a high-throughput, inkjet based single-cell printer enabled by specialized optics and machine vision. We have already established the basic parameters of our Isolatrix technology, and demonstrated through testing that the concept will function for its intended purpose in single cell dispensing. Single-particle dispense rates of greater than 90% are achieved at a speed of less than 2 seconds per dispensed particle. The system is designed to be compatible with a range of substrate footprints ranging in size from standard microtiter plates to microwell chips. In this Phase 1 project we will address the essential questions asked through our Market Assessment, and through validation of the technology with our partner at the BC Cancer Research Centre, we will advance the technology and demonstrate its application for single-cell genomics studies, enabling projects that are currently limited by the time required for single cell isolation.
Programme
Idea to Innovation
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
544495-2019
Name nom
Cheung, Karen
Department département
Electrical and Computer Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
A Single Cell Isolating System for Genomics Applications, Phase 1 I2I
Keyword
NSERC
Application summary
The UBC Isolatrix printer will be a cost-effective solution to fill an unmet need for single-cell preparation for numerous use cases. Current methods for single-cell isolation include random encapsulation and micromanipulation. Random encapsulation following the Poisson distribution gives a low fill factor with a large number of empty wells or droplets, while current tools using micromanipulation can increase the fill factor but with high shear force on cells, or high processing time. Our system is a high-throughput, inkjet based single-cell printer enabled by specialized optics and machine vision. We have already established the basic parameters of our Isolatrix technology, and demonstrated through testing that the concept will function for its intended purpose in single cell dispensing. Single-particle dispense rates of greater than 90% are achieved at a speed of less than 2 seconds per dispensed particle. The system is designed to be compatible with a range of substrate footprints ranging in size from standard microtiter plates to microwell chips. In this Phase 1 project we will address the essential questions asked through our Market Assessment, and through validation of the technology with our partner at the BC Cancer Research Centre, we will advance the technology and demonstrate its application for single-cell genomics studies, enabling projects that are currently limited by the time required for single cell isolation.